Enjoy complimentary customisation on priority with our Enterprise License!
The global bilirubin blood test market size is estimated to grow by USD 552.66 million at a CAGR of 6.24% between 2023 and 2028.
The global bilirubin blood test market players are focusing on the development of high-quality, advanced, and innovative products for bilirubin blood tests. Advances in medical technology are expanding the product offerings of bilirubin blood tests, which can effectively provide results for the diagnosis of bilirubin. For instance, Koninklijke Philips NV offers the BiliCheck System, a non-invasive, transcutaneous bilirubinometer that assesses the risk of jaundice in newborns. This test uses light instead of a needle to measure the serum bilirubin level. Thus, technological advances in devices used for analyzing bilirubin levels in the blood are expected to boost the growth of the global bilirubin blood test market during the forecast period.
Technavio has segmented the market into End-user, Product Type, and Geography
It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2018 - 2022, besides analyzing the current market scenario.
To learn more about this report, Download Report Sample
The market share growth by the infants segment will be significant during the forecast period. Factors such as the increasing prevalence of neonatal jaundice, new product launches, government guidelines to create awareness regarding neonatal jaundice, and the presence of established players with a strong product portfolio will boost the growth of this segment in the next five years.
Get a glance at the market contribution of various segments Download PDF Sample
The infants segment was valued at USD 796.50 million in 2018. The major factor augmenting the growth of the infant segment is the increasing prevalence of neonatal jaundice. In addition, market players offer a wide range of products for bilirubin blood tests in infants. For instance, Siemens Healthineers (a part of Siemens AG) offers ADVIA Chemistry Total Bilirubin_2 (TBIL_2). The product is used for the quantitative determination of total bilirubin in serum and plasma of neonates. Thus, such factors are expected to boost the growth of the infant segment of the global bilirubin blood test market during the forecast period.
The instruments product segment of the bilirubin blood test market includes devices such as spectrophotometers and analyzers designed for measuring bilirubin levels in blood samples. These instruments play an important role in diagnostic laboratories and healthcare settings to assess liver function and detect conditions such as jaundice. The market for bilirubin blood test instruments is influenced by technological advancements, automation, and the high demand for efficient and accurate diagnostic tools in clinical practice. The instruments product segment of the bilirubin blood test market is experiencing notable growth, driven by several factors such as technological advancements, rising incidence of liver disorders, and global awareness about screening programs. Therefore, the instruments segment of the global bilirubin blood test market is expected to grow during the forecast period.
The consumables product segment in the global bilirubin blood test market includes various items that are essential for conducting bilirubin tests, such as reagents, calibrators, control materials, pipette tips, tubes, sample cups or containers, filters, assay kits, and cleaning solutions. These consumables are disposable or single-use items used during the testing process, and they play a critical role in sample collection, preparation, and analysis. In addition, manufacturers are investing in research and development to enhance the performance of consumables. Furthermore, disposable consumables, such as pipette tips and sample containers, contribute to infection control measures in laboratories. The emphasis on preventing cross-contamination supports the use of single-use consumables. These factors are expected to drive the growth of the consumables segment of the global bilirubin
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Due to the increasing technological advances in bilirubin blood testing products and product launches, the increasing prevalence of chronic liver diseases and jaundice, and the presence of favorable insurance coverage, the bilirubin blood test market in North America is expected to grow at a moderate rate.
Moreover, the level of bilirubin in the blood of patients with hepatitis C is unstable. Similarly, prolonged periods of high bilirubin levels suggest severe liver disease and possibly cirrhosis. Thus, patients diagnosed with liver diseases such as hepatitis must regularly measure their bilirubin levels to prevent the occurrence of jaundice or severe liver damage. The rising incidences of liver disease, coupled with the growing demand for diagnosis, are expected to boost the growth of the bilirubin blood test market during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:
Micro Lab Instruments: The company offers bilirubin blood test instrument such as Microlab EasyBill-P Bilirubinometer which provides quick, easy and accurate results of total bilirubin in whole blood of paediatrics samples with volume of 50-80ul.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.
The increasing incidence of preterm births is the key factor driving market growth. The number of preterm births has increased at a rapid pace globally over the past few years, mainly in developing economies like India. In some developing countries, medically unnecessary inductions and cesarean deliveries before full-term have also increased the number of preterm births. In low-developed countries like Bangladesh, Afghanistan, and Central Africa, the main causes of preterm births include infections, malaria, HIV, and high adolescent pregnancy rates. Preterm births are a major risk factor for jaundice in newborns.
Furthermore, The American Academy of Pediatrics recommends that all babies should be checked for jaundice after birth while they are in the hospital. According to the OECD, in Asia, the number of premature infants is increasing. Low-birth-weight newborns are at major risk of developing jaundice, which can lead to bilirubin encephalopathy. The increasing number of premature infants will increase the adoption of bilirubin testing, which will drive the growth of the global bilirubin blood test market during the forecast period.
Government initiatives and funding for bilirubin testing is the primary trend shaping market growth. The prevalence of jaundice and liver diseases is increasing globally, due to the rising incidences of preterm births and the prevalence of unhealthy lifestyles. These factors are likely to increase the demand for bilirubin blood testing and drive the growth of the market in the next five years. Owing to the growing prevalence of neonatal jaundice, many governments and non-profit organizations are taking initiatives to increase awareness of neonatal jaundice and the benefits of early detection of the disease through the quantification of bilirubin levels.
Moreover, governments are increasingly promoting campaigns that focus on the causes and early detection of jaundice, which include bilirubin testing in newborns to prevent them from developing jaundice. Thus, the growing number of such programs conducted by government bodies to create awareness about preventive care and regular monitoring of bilirubin levels in neonates will boost market growth during the forecast period.
The dearth of skilled workforce and advanced infrastructure in developing countries is a challenge that affects market growth. The manufacturing and use of blood bilirubin testing devices require skilled nurses and laboratory professionals. According to The World Bank Group, the information on the public sector shows the relative scarcity of highly qualified laboratory professionals. Laboratory staffing levels range from 0.01 to 1.3 per 1,000 inhabitants, with the majority of countries recording levels below 0.1 per 1,000 inhabitants in developing countries.
Furthermore, the healthcare infrastructure in developing countries lacks advanced technologies and devices, mainly owing to poor investments by government organizations. Hence, the dearth of skilled, trained professionals, the presence of poor healthcare infrastructure, and the lack of awareness about advanced technologies in developing countries will impede the growth of the global bilirubin blood test market during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Bilirubin Blood Test Market Customer Landscape
The bilirubin blood test market report forecasts market growth by revenue at global, regional & country levels and analyzes the latest trends and growth opportunities from 2018 to 2028.
Bilirubin Blood Test Market Scope |
|
Report Coverage |
Details |
Page number |
160 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.24% |
Market Growth 2024-2028 |
USD 552.66 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
5.75 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 38% |
Key countries |
US, Germany, UK, France, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Abbott Laboratories, Advanced Instruments LLC, ALLMEDTECH, AMETEK Inc., Anamol Laboratories Pvt. Ltd., BIOGENIX Inc. Pvt. Ltd., DiaSys Diagnostic Systems GmbH, Dragerwerk AG and Co. KGaA, ELITechGroup SAS, F. Hoffmann La Roche Ltd., GINEVRI Srl, Jaiprakash Associates Ltd., Koninklijke Philips N.V., Mega Lab SA, Merck KGaA, Micro Lab Instruments, Randox Laboratories Ltd., Siemens AG, Teco Diagnostics, and Thermo Fisher Scientific Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Product Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.